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This study was undertaken to evaluate the hypoglycemic effect of methanol extract of securinega 
virosa leaves on blood levels of streptozocin-induced diabetes rats. Three doses of the extract (100, 300 
and 600 mg/kg) were administered intraperitoneally. After 2 h of extract administration there was no 
significant change in the blood glucose levels in all the three doses of the extract. Also after 4, 8 and 24 
h of extract administration there was a significant (p < 0.05 - 0.001) decrease in the blood glucose levels 
in all the three doses of the extract. The preliminary phytochemical screening revealed the presence of 
reducing sugars, cardiac glycosides, resin, tannins, saponins, glycosides, flavonoids, glycerin 
carbohydrate, anthraquine and steroids. The median lethal dose (LD50) in rats was calculated to be 
1264.9 mg/kg body weight.  
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Diabetes is one of the oldest known diseases of the man 
whose devastating effect is increasing by the day and 
severity almost at epidemic level. It is a disease of 
disordered metabolism of carbohydrate, protein and fat 
which is caused by the complete or relative insufficiency 
of insulin secretion and /or insulin action (Balkau et al., 
2000). The number of people suffering from the disease 
worldwide is increasing at an alarming rate with a 
projected 366 million peoples likely to de diabetic by the 
year 2030 as against 191 million estimated in 2000 (Wild 
et al., 2004). Developing countries are the most affected 
because of expensive and inadequate treatments (Djrolo 
et al., 1998), coupled with the side effect associated with 
these drugs. Thus the search for a new drug with low 
cost, more potential and without adverse effects becomes 
inevitable. A great number of medicinal plants have been 
used in the treatment of diabetes in different parts of the 
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though World Health Organization (WHO) had encour-
aged and recommended the use of plants as an 
alternative therapy for diabetes (WHO, 1980). Evaluation 
of the antidiabetic potentials of these plants becomes 
necessary to provide scientific proof and justify their uses 
in ethnomedicine. 
Securinega virosa is one of the great African medicinal 
plants described as a true “cure all”, of which all parts are 
used as remedies, particularly the root (Neuwinger, 
1996). It is widely distributed throughout tropical Africa, 
but can also be found in India, Malaya, china and Aus-
tralia (Dalziel, 1936) The leaves are used in many parts 
of Africa in the treatment of fever, body pain, stomach-
ache rheumatism, diarrhea, pneumonia and epilepsy 
(Neuwinger, 1996). The present study was designed to 
test the hypoglycemic effect of methanol extract of S. 
virosa leaves in streptozocin-induced diabetes. 
 
 
MATERIAL AND METHODS  
 
Plant material  
 





Sabon-gari Local Government Area of Kaduna State, Nigeria, in 
May 2006. The plant was identified and authenticated by Malam M. 
Musa of the Herbarium Section in the Department of Biological 
Sciences, Ahmadu Bello University, Zaria,Nigeria. A voucher 






The leaves were cleaned, air dried for 14 days and then crushed 
into coarse powder with a pestle and mortar. 100 g of the powered 
leaves was extracted with 500 ml methanol for 72 h using Soxhlet 
extraction apparatus. The solvent was evaporated on a water bath 
to give an average yield of 12.63% (w/w). The extract was then 
stored in a desiccator. Solutions of the extract were prepared 









Acute toxicity study       
 
The lethal dose (LD50) of the plant extract was determined by 
method of Lorke (1983) using 13 rats. In the first phase rats were 
divided into 3 groups of 3 rats each and were treated with the 
methanol extract of the leaves at doses of 10, 100 and 1000 mg/kg 
body weight intraperitoneally. They were observed for 24 h for signs 
of toxicity. In the second phase 4 rats were divided into 4 groups of 
1 rat each and were also treated with the methanol leaves extract at 
doses of 600, 1000, 1600 and 2900 mg/kg bodyweight (ip). The 





The methanol extract of the leaves obtained was subjected to 
preliminary phytochemical screening, to identify the chemical 
constituents. The methods of analysis employed were those 
described by Trease and Evans (1989). 
 
 
Animals and Induction of diabetes mellitus 
 
Twenty five Wistar rats of both sexes weighing 120 - 180 g were 
used for the study of the effects of methanol extract of S. virosa 
leaves on the blood glucose levels of the animals. They were kept 
in standard cages at 250C and 12 h light/dark condition in the 
animal room of the Department of Human Physiology, ABU, Zaria. 
The animals were fed on commercial feeds and were given water 
ad libitum. The animals were fasted from feeds for 12 h before the 
commencement of each experiment, but were allowed water ad 
libitum. The rats were injected with streptozocin dissolved in citrate 
buffer pH 4.5 in a dose of 60 mg/kg body weight intraperitoneally. 
Since Streptozocin is capable of producing fatal hypoglycemia as a 
result of massive pancreatic release of insulin, the rats were treated 
with 20% glucose solution intraperitoneally after 6 h (Stanley and 
Venugopal, 2001). They were kept for the next 24 h on 5% glucose 
solution to prevent hypoglycemia (Stanley and Venugopal, 1997). 
After a period of one week the rats with blood glucose levels 
greater than 200 mg/dl were considered diabetic and used for this 
research work.  






The Streptozocin-induced diabetic Wistar rats were randomly 
assigned into five groups (1 - 5) of five rats (n = 5) each as follows; 
Group 1 received normal saline i.p; Group 2 received biphasic 
isophane insulin 6 i.u/kg i.p (Stanley and Venugopal, 2001); Group 
3 received 100 mg/kg body weight of the methanol extract of S. 
virosa leaves i.p; Group 4 received 300 mg/kg body weight of the 
methanol extract of the leaves i.p; and Group 5 received 600 mg/kg 
body weight of the methanol extract of the leaves i.p. 
 
 
Determination of blood glucose levels 
 
All blood samples were collected by cutting the tail-tip of the rats. 
Blood samples for blood glucose determination were collected from 
the tail at intervals of 0, 2, 4, 8 and 24 h. Determination of the blood 
glucose level was done by the glucose-oxidase principle (Beach 
and Turner, 1958) using the ONE TOUCH Basic (Lifescan, Milpitas, 






Blood glucose levels were expressed in mg/dl as mean ± SEM. The 
data were statistically analyzed using ANOVA with multiple compa-
risons versus control group. The values of p < 0.05 were 
considered as significant (Duncan et al., 1977). 
 
 




Many secondary metabolites participate in a variety of 
anti-diabetic functions in vivo (Kako et al., 1997). Freshly 
prepared extracts were subjected to preliminary phyto-
chemical screening test for various constituents. This 
revealed the presence of reducing sugars, cardiac glycol-
sides, resin, tannins, saponins, glycosides, flavonoids, 
glycerin carbohydrate anthraquine and steroids.  
 
 
Acute toxicity study (LD50)  
 
The sign of toxicity were first noticed after 2 – 4 h of 
extract administration. There was decreased locomotor 
activity and decreased in sensitivity to touch. Also there 
was decreased feed intake and prostration after 4 h of 
extract administration. The median lethal dose (LD50) in 





Streptozocin-induced hyperglycaemia has been describe-
ed as a useful experimental model to study the activity of 
hypoglycaemic agents (Szkudelski, 2001). Streptozocin 
selectively destroyed the pancreatic insulin secreting -
cells, leaving less active cell and resulting in a diabetic 
state  (Kamchouing et al., 1998; Szkudelski, 2001). Table  


















Vales are given as mean ± SD for 5 rats in each group.  
Experimental groups were compared with diabetic control. Values are statistically significant at a = P < 0.05; b = P < 0.01; and c = P 
< 0.001.  




1 shows the results of the effects of three doses (100, 300 
and 600 mg/Kg) of the methanol extract of S. virosa leaves, 
insulin and control groups in streptozocin-induced diabetic 
Wistar rats. The insulin and the three doses of the extract 
did not show any significant change in the blood glucose 
levels when compared to untreated control after 2 h. 
However, after 4, 8 and 24 h of treatments the extract 
showed a significant (p < 0.05 - 0.001) decrease in the blood 
glucose levels when compared to untreated control. The 100 
mg/kg dose which is the lowest dose was found to be more 
effective in the glycaemic change than the other two doses 





The study indicates that the methanol extract of S. virosa 
leaves possess anti-diabetic properties which suggest the 
presence of biologically active components. The extract 
might be promoting glucose uptake and metabolism or 
inhibiting hepatic gluconeogenesis. Result from the 
phytochemical analysis of S. virosa revealed the 
presence of flavonoids, which has also been isolated 
from the other plant and found to stimulate secretion or 
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Blood glucose level (mg/dl)  
Treatment 0 h 2 h 4 h 8 h 24 h 
Group 1 
Control  (Saline) 
277.0 ± 434.9 318.2 ± 27.4 330.6 ± 30.7 322.4 ± 28.9 328.2 ± 29.9 
Group 2  
(Insulin 6.i.u/kg) 
272.8 ± 43.1 ns 239.4 ± 36.6 ns 188.4 ± 23.0 c 149.4 ± 16.6 c 137.0 ± 12.1c 
Group 3 
(100 mg/kg) 
273.2 ± 36.2 ns 238.2 ± 25.5 ns 205.4 ± 15.5 c 185.6 ± 9.35 c 165.4 ± 16.5 c 
Group 4 
(300 mg/kg) 
277.4 ± 21.5 ns 256.2 ± 15.87 ns 219.8 ± 14.8 b 196.2 ± 16.4 c 
 




271.0 ± 29.2 ns 264.4. ± 26.7 ns 252.0 ± 21.2 b 238.2 ± 22.4 b 199.0 ± 22.0b 
